- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 76.88M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 68.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 21.33M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.06M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.73M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.16M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$12.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$24.22M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$18.84M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12.21M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $11.56M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $19.27M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $20.33M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $27.68M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.28M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $29.82M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $8.56M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.29 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.29 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.64M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.75M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.35M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.96M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.11M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $313K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $226K |
| Revenue | Q1 2026 · Mar 31, 2026 | $39K |
| Revenue | Q1 2026 · Mar 31, 2025 | $46K |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $1.21M |
| Capex | Q1 2026 · Mar 31, 2025 | $6K |